SCHEMBL34464722

SCHEMBL34464722

CCCCC(CC)Cn1cc(C)c(=O)n(CCCO)c1=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPC5 Q9UL62 2/20 0.40
PDE4A P27815 2/20 0.37
PDE4B Q07343 2/20 0.37
PDE4C Q08493 2/20 0.37
PDE4D Q08499 2/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
MAPT P10636 3/20 0.36
TP53 P04637 1/20 0.36
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
BCL2L1 Q07817 1/20 0.34
CA2 P00918 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.32
TYR P14679 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34464728 0.90 MAPT (0.38) TRPC5PDE4APDE4BPDE4CPDE4D
SCHEMBL34464729 0.90 MAPT (0.38) TRPC5PDE4APDE4BPDE4CPDE4D
SCHEMBL11241059 0.68 BCL2L1 (0.37) MAPTTP53ALDH1A1TSHRKDM4E
SCHEMBL34464723 0.66 SLC9A1 (0.41) ADORA2AMAPTTP53ALDH1A1TSHR
SCHEMBL30982575 0.66 TYR (0.49) ALDH1A1BCL2L1CA2CYP3A4TYR
SCHEMBL34464717 0.66 TRPC5 (0.37) TRPC5PDE4APDE4BPDE4CPDE4D
SCHEMBL11428293 0.66 BCL2L1 (0.36) MAPTTP53ALDH1A1TSHRKDM4E
SCHEMBL11236043 0.66 ALDH1A1 (0.37) MAPTTP53ALDH1A1TSHRKDM4E
SCHEMBL30982429 0.66 ALDH1A1 (0.37) MAPTTP53ALDH1A1TSHRKDM4E
SCHEMBL7606566 0.66 TRPC5 (0.43) TRPC5PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, ERCC5, ERCC4 TRPC5 1860/4885PDE4A 4073/4885PDE4B 4570/4885
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, PDE6H, HCK TRPC5 1311/4885PDE4A 3917/4885PDE4B 4342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.